Inhalational glucocorticoids in broncial asthma therapy

1. Кахановский И.М., Соломатин А.С. Беклометазона дипропионат, будесонид и флунизолид в лечении бронхиальной астмы (обзор литературы и собственные исследования) / / Тер. арх.—1995.— № 3.— С.34—38.

2. Кромптон Т.К. Ингаляционная система Турбугалер. Клиническая монография.— Oxford, 1993.

3. Отчет о международном соглашении по диагностике и лечению бронхиальной астмы.— Вена, 1992. (На русском языке с согласия Eur.Respir.J.— 1992.— Vol.5. P.601—641).

4. Чучалин А.Г., Хамид ИМ. Бронхиальная астма. Сальбутамол.— М., 1992.— С.4—66.

5. Шимбах X., Кнаппе Г. Гормонотерапия.— М., 1988.

6. Adelroth Е., Rosenhall L., Johansson S-A., Lindon М., Venge P. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage / / Am.Rev.Respir.Dis.—1990.— Vol.142.— P.91—99.

7. Agertoft L., Pedersen S. Importance of the inhalation device on the effect of budesonide / / Arch.Dis.Child.— 1993.— Vol.69.—P.130— 133.

8. Ali N.J., Capewel S., Ward M.J. Bone turnover during high dose inhaled corticosteroid therapy / / Thorax.— 1991.— Vol.46.—P. 160—64.

9. Anderson P., Ryrfeldt A. Biotransformation of the topical glucocorticoids budesonid and beclomethason 17-alpha, 21-dipropionate in human liver and lung homogenate / / J.Pharmacol.— 1984.—Vol.36.— P.763—5.

10. Balfour-Lynn L. Growth retardation in asthmatic children treated with inhaled beclomethasone dipropionate / / Lancet.— 1988.—Vol. 1.— P.475.

11. Barnes P.J. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma / / J.Allergy Clin. Immunol.—1989.— Vol.83.— P. 1013— 1026.

12. Barnes N.C. et al. A comparison of fluticasone propionate, 1mg daily with beclomethasone dipropionate, 2mg daily, in the treatment of severe asthma / / Eur.Respir.J.— 1993.— Vol.6.—P.877—884.

13. Bisgard H., Pedersen S., Damkjaer Nielsen М., Osterballe O. Adrenal function in asthmatic children treated with inhaled budesonide / / Acta Paediatr.Scand.— 1991.— Vol.80.— P.213—217.

14. Boe J. et al. Comparison of dose-response effects of inhaled beclomethasone dipropionate and budesonide in management of asthma / / Allergy.— 1989.— Vol.44.— P.349.

15. Borson D.B., Gruenert D.C. Glucocorticoids induce neutral endopeptidase in transformed human tracheal epithelial cells / / Am.J. Physiol.— 1991.— Vol.260.— P.83—89.

16. Brat t sand R., Thalen A., Roempke K., Kallstrom L., Gruvstad E. Development of new glucocorticoids with a very high ratio between topical and systemic activines / / Eur.J.Respir.Dis.— 1982.— Vol.63, Suppl. 122.— P.62—73.

17. Brokbank W., Brebner H., Pengelly C.D.R. Chronic asthma treated with aerosol hydrocortisone / / Lancet.— 1956.— Vol.2.— P.807.

18. Brown P.H., Blundell G., Greening A.P., Crompton G.K. Hypothalamopituitary-adrenal axis supression in asthmatics inhaling high dose corticosteroids / / Respir.Med.— 1991.— Vol.85.—P.501—510.

19. Burke C., Powe r C.K., Norris A., Condes A., Schmekel B. et al. Lung function immunopathological changes after inhaled corticosteroid therapy in asthma / / Eur.Respir.J.— 1992.— Vol.5.—P.73—79.

20. Chaplin M.D., Cooper W.C., Segre E.J., Oren J., Jones R.E., Nerenberg C. Correlation of flunisolide plasma levels to eosinopenia response in humans / / J.Allergy Clin.Immunol.— 1980.— Vol.65.— P.445—453.

21. Chaplin M.D., Rooks W., Swenson E. W., Cooper W.E., Nerenberg C., Chee N.L. Flunisolide metabolism and dynamics of a metabolite / / Clin.Pharmacol.Ther.— 1980.— Vol.27.— P.402—413.

22. Chim C.S. Inhalation aids of metered dose inhalers / / Chest.—1987,— Vol.9 1.— P.315.

23. Clark T.J.H. Effect of beclomethasone dipropionate delivered by aerosol in patients with asthma / / Lancet.— 1972.— VOL.l.— P.1361-1364.

24. Clissold S.P., Heel R.C. Budesonide: a preliminary review of its pharmacodynamic properties and therapeutic efficacy in asthma and rhinitis / / Drugs.— 1984.— Vol.28.— P.485—518.

25. Cox G., Ohtoshi T., Vancheri C. et al. Promotion of eosinophil survival by human bronchial epithelial cells and its modulation by steroids / / Am.J.Respir.Cell Mol.Biol.— 1991.— Vol.4.— P.525—531.

26. Crompton G.K. Problems patients have using pressurized aerosol inhalers / / Eur.J.Respir.Dis.— 1982.— Vol.l19, Suppl.— P.101 — 104.

27. Dahl R., Oilman A. Efficacy of inhaled corticosteroids / / Asthma Management. Topics for the 90s. A Symposium Report. Clinical Vision Ltd. 2-nd Ed.— Helsinki, 1994.— P. 18-23.

28. Dechatean G.S.M.J.E., Zuidema J., Merkus H.M. The in vitro and in vivo effect of a new non-halogenated corticosteroid — budesonide-aerosol on human ciliary epithelial function / / Allergy.— 1986.— Vol.41.— P.260-265.

29. De Graaft C.S., van den Bergh J.A.H.M., d e Bree A.F., Stallaert R.A.L.M., Prins J., van Lier A.A. A double blind clinical comparison of budesonide and beclomethasone dipropionate (BDP) given as dry powder formulations in asthma / / Eur.Respir.J.— 1992.— Vol.5, Suppl.15,— P.359s.

30. Djukanovic R., Wilson J., Britten K., Wilson S., Walls A., Roche W., Howarth P., Holgate S.T. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry / / Am.Rev.Respir.Dis.— 1990.— Vol. 142.— P.863—871.

31. D’Souza W., Beasley R., Te Karu H. et al. Trial of credit card asthma action plan (CCAP) in a Maori community / / Eur. Respir.J.— 1992.— Vol.5, Suppl. 15.— P.95.

32. Evans M., O'Connor B.J., Fuller R.W., Chung K.F., Barnes P.J. Effect of inhaled budesonide on eosinophil density in asthma / / Br.J.Clin.Pharmacol.— 1991,— Vol.31.— P.616P.

33. Fabbri L., Burge P.S., Croonenborgh L., Warlies F., Weeke B., Ciaccia A., Parker C. On behalf of an internationale study group. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year / / Thorax.— 1993.— Vol.48.— P.817—423.

34. Fancourt G.J., Ebden P., Me Nal ly P. The effects of high dose (2000 m e g /d a y ) inhaled beclomethasone dipropionate on glucose tolerance in diet controlled elderly diabetic subjects / / Eur. Respir.J.— 1988.— VOL.l, Suppl.2.— P. 196s.

35. Feldman D., Funder J., Loose D. Is the glucocorticoid receptor identical in various target organs? / / J.Steroid Biochem.— 1978.— Vol.9.— P. 141 — 145.

36. Fitzsimons R., Greenberger P.A., Patterson R. Outcome of pregnancy in vomen requiring corticosteroids fore severe asthma / / J.Allergy Clin.Immunol.— 1986.— Vol.78.— P.349.

37. Foresi A., Bertorelli G., Pesci A., Chetta A., Oliveri D. Inflammatory marcers in bronchoalveolar lavage and in bronchial biopsy in asthma during remission / / Chest.— 1990.— Vol.98.— P.528—535.

38. Frank A., Dash C.H. Inhaled beclomethasone dipropionate in acute infections of the respiratory tract / / Respiration.— 1985.— Vol.48.— P.122.

39. Fuller R.W., Kelsey C.R., Cole P.J., Dollery C.T., Mac Dermot J. Dexamethasone inhibits the production of thromboxane B-2 and leukotriene B-4 by human alveolar and peritoneal macrophages in culture / / Clin.Sei.— 1984,— Vol.67.— P.653-656.

40. Harding S.M. The human pharmacology of fluticasone propionate / / Respir.Med.— 1990,— Vol.84, Suppl.A.— P.25—29.

41. Horton D.J., Spector S.L. Clinical pulmonary tuberculosis in an asthmatic patient using a steroid aerosol / / Chest.— 1977.— Vol.71.— P.540.

42. Jeffery P.K., Godfrey W.f Adelroth E. et al. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. / / Am.Rev.Respir.Dis.— 1992.— Vol. 145.— P.890—899.

43. Jennings B.H., Andersson K.-E., Johansson S.-A. Assessment of the systemic effects of inhaled glucocorticosteroids: the influence of blood sampling technique and frequency on plasma cortisol and leucocytes / / Eur.J.Clin.Pharmacol.— 1990.— Vol.39.— P.127— 131.

44. Jennings B.H., Andersson K.-E., Johansson S.-A. Assessment of systemic effects of inhaled glucocorticosteroids: comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover / / Eur.J.Clin.Pharmacol.— 1991.— Vol.40.— P.77-82.

45. Jennings B.H., Andersson K.-E., Johansson S.-A. The assessment of the systemic effects of inhaled glucocorticosteroids. The effects of inhaled budesonide with oral prednisolone of calcium metabolism / / Ibid.— Vol.41.— P.ll — 16.

46. Johansson S.A., Andersson K.E., Brattsand R., Gruvstad E., Hedner P. Topical and systemic glucocorticoid potenties of budesonide and beclomethasone dipropionate in man / / Eur.J. Respir.Dis.— 1982.— Vol.63, Suppl.122.— P.74—82.

47. Juniper E.F., Kline P.A., Vanzieleghem M.A., Hargreave F.E. Reduction of budesonide after a year on increased use: a randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained / / J.Allergy Clin.Immunol.— 1991.— Vol.87.— P.483—489.

48. Kewley G.D. Possible association between beclomethasone dipropionate aerosole and cataracts / / Aust.Paediatr.J.— 1980.— Vol.16.— P.117.

49. Laitinen A. Bronchial biopsies in the assessment of asthma and its treatment / / Asthma Management. Topics for the 90s. A Symposium Report. Clinical Vision Ltd. 2-nd Ed.— Helsinki, 1994.— P.14— 17.

50. Laitinen L.A., Laitinen A., Heino M., Haahtela T. Eosinophilic airway inflammation during exacerbation of asthma and its treatment with inhaled corticosteroid / / Am.Rev.Respir.Dis.— 1991.— Vol. 143.— P.423—427.

51. Laitinen L.A., Laitinen A., Haahtela T. Treatment of eosinophilic airway inflammation with inhaled corticosteroid, budesonide, in newly diagnosed asthmatic patients (abstract) / / Eur.Respir.J.— 1991.— Vol.4, Suppl.14.— P.342S.

52. Langlands J.H., Me Neill R.S. Hydrocortisone by inhalation. Effects on lung function in bronchial asthma / / Lancet.— 1960.— Vol.2.— P.404—406.

53. Laursen L.C. et al. Fiberotic bronchoscopy and bronchial mucosal biopsies in asthmatics undergoing long-term high-dose budesonide aerosol treatment / / Allergy.— 1988.— Vol.43.— P.284.

54. Lee P.S., Camplell L.M., Watson D.G. et al. Budesonide Turbohaler onse daily in mild asthma. Abstract / / Thorax.— 1991.— Vol.46.— P.769P.

55. Lundgren R. et al. Morphological studies of bronchial biopsies from asthmatics before and after ten years of treatment with inhaled steroids / / Eur.Respir.J.— 1988.— VOL.l.— P.883.

56. Lundgren R. Scanning electron microscope studies of bronchial mucosa before and during treatment with beclomethasone dipropionate inhalation / / Scand.J.Respir.Dis.— 1977.— Vol.57, Suppl.101.— P. 179-187.

57. Mar tin L.E., Harrison G., Tanner R.J.N. Metabolism of beclomethasone dipropionate by animals and man / / Postgrad. Med.J.— 1975,— Vol.51, Suppl.4.— P. l l—20.

58. Moren F. Drug deposition of pressurized inhalation aerosols / / Int.J.Pharmacol.— 1978,— VOL.l.— P.205-212.

59. Morrow-Brown H., Storey G., George W.H.S. Beclomethasone dipropionate: a new steroid aerosol for the treatment of allergic asthma / / Br.Med.J.— 1972.— VOL.l.— P.585—590.

60. Nassif E. et al. Extrapulmonary effects of maintenance corticosteroid with alternate-day prednisone and inhaled beclomethasone in children with chronic asthma / / N.Engl.J.Med.— 1981.—Vol.304.— P.71.

61. Newman S.P., Pav ia D., Garland N. Effects of various inhalation modes on the deposition of radioactive pressurized aerosols / / Eur.J.Respir.Dis.— 1982.— Vol.63, Suppl.119.— P.57—65.

62. Newman S.P., Miller A. B., Lennard-Jones T.R., Moren F, Clarke S. W. Improvement of pressnrized aerosol deposition with Ncbuhaler spacer device / / Thorax.— 1984.— Vol.39.— P.935—941.

63. Ninan T.K., Russel G. Asthma inhaled corticosteroid treatment and growth / / Arch.Dis.Child.— 1992.— Vol.67.— P.703—705.

64. Pakes G.E., Brogden R.N., Heel R.C., Speight T.M., Avery G.S. Flunisolide: a review of its pharmacological properties and therapeutic efficacy in rhinitis / / Drug.— 1980.— Vol.19.— P.397—411.

65. Pedersen S., Steffensen G., Ekman I., Tonnesson M., Borga O. Pharmacokinetics of budesonide in children with asthma / / Eur.J.Clin.Pharmacol.— 1987.— Vol.3 1.— P.579—582.

66. Persson C.G.A. Antiinflammatory therapy with glucocorticoids in intrinsic asthma / / Agents and Action.— 1989.— Vol.28, Suppl.— P.279—291.

67. Phillips G.H. Structure — activity relationships of topically active steroids: the selection of fluticasone propionate / / Respir.Med.— 1990.— Vol.84, Suppl.A.— P.19—23.

68. Prahl P. Adrenocortical suppression following treatment with beclomethasone and budesonide / / Clin.Exp.Allergy.— 1991.— Vol.21,— P.145— 146.

69. Prachl P., Jensen T. Decreased adrenocortical supression utilizing the Nebuhaler for inhalation of steroid aerosols / / Clin.Allergy.— 1987,— Vol.17.— P.393—398.

70. Priftis K., Everard M.L., Milner A.D. Unexpected side-effects of inhaled steroids: a case report / / Eur.J.Pediatr.— 1991.— Vol. 150,— P.448—449.

71. Reed Ch.E. Aerosol Glucocorticoid treatment of asthma / / Am.Rev.Respir.Dis.— 1990.— Vol. 141, № 2.— P.82—88.

72. Reed C.E. Aerosol steroids as primary treatment of mild asthma. Editorial / / N.Engl.J.Med.— 1991.— Vol.325.— P.425—426.

73. Ryrfeldt A., Andersson P., Edsbacker S., Tonnesson M., Davies D., Panwels R. Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid / / Eur.J.Respir.Dis.— 1982.— Vol.63, Suppl.122.— P.86—95.

74. Schatz M., Patterson R. Tuberculosis and isoniazid in steroid-treated asthmatic patients / / Ann.Intern.Med.— 1976.— Vol.85.— P.129.

75. Schurmeyer T.H., Tsokos G.C., Avger ihos P.C. et al. Pituitaryadrenal responsiveness to corticotropin-releasing hormone in patients receiving chronic, alternate day glucocorticoid therapy / / J.Clin.Endocrinol.Metab.— 1985.— Vol.61.— P.22—27.

76. Selroos O., Backman R., Lofroos A.B., Niemisto M., Pietinahlo A., Aikas C., Riska H. Pulmicort Turbuhaler treatment is associated with a significantly reduced frequency of local side-effects compared to steroid MDIs with spacer / / Allergy.— 1993.— Vol.48, Suppl.15.— P.98.

77. Selroos O., Halme M. Effect of a volumatic spacer and mouth rinsing on systemic a metered dose inhaler and dry powder inhaler / / Thorax.— 1991.— Vol.46.— P.891—894.

78. Selroos O. Maintenance treatment in chronic asthma. Asthma Management. Topics for the 90s. A Symposium Report. Clinical Vision Ltd. 2-nd. Ed.— Helsinki, P.24—26.

79. Sterk P. Effects of therapy on bronchial hyperresponsiveness / / Ibid.— P.13— 14.

80. Svendsen U.G. Fluticasone propionate (a new inhaled steroid): clinical developments in mild to moderate adult asthmatics / / Eur.Respir.J.— 1990.— Vol.3, Suppl.10.— 250s.— P.S924.

81. Tarlo S., Broder I. et al. Six-month double-blind, controlled trial of high dose, concentrated beclomethasone dipropionate in the treatment of severe chronic asthma / / Chest.— 1988.— Vol.93.— P.988— 1002.

82. Taylor A.L., Fishman L.M. Corticotropin-releasing hormone / / N.Engl.J.Med.— 1988,— Vol.319.— P.213—222.

83. Thorsoon L., Edsbacker S., Conradson T.B. Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered dose inhaler (pMDI) / / Thorax.— 1993.— Vol.48.—P.434.

84. Toogood J.H. et al. A study of mechanism of the asthmatic action of inhaled budesonide / / J.Allergy Clin.Immunol.— 1990.—Vol.85.— P.872.

85. Toogood J.H. Concentrated aerosol formulations in asthma / / Lancet.— 1983,— Vol. 2-.— P.790.

86. Toogood J.H. Complications of topical steroid therapy for asthma / / Am.Rev.Respir.Dis.— 1990.— Vol. 141.— P.89—96.

87. Toogood J.H. et al. Candidiasis and dysphonia complicating beclomethasone treatment of asthma / / J.Allergy Clin.Immunol.—1980.— Vol.65.— P.145— 153.

88. Toogood J.H. et al. Dosing regimen of budesonide and occurrence of oropharyngeal complications / / Eur.J.Respir.Dis.— 1984.— Vol.65.— P.35.

89. Toogood J.H. et al. Effects of dose and dosing schedule of inhaled budesonide on bone turnover / / J.Allergy Clin.Immunol.— 1991.— Vol.88.— P.572.

90. Toogood J.H. et al. Risk of posterior subcapsular cataracts (PSC) during oral and inhaled steroid therapy for asthma / / Clin. Invest.Med.— 1992.— Vol. 15, Suppl.10.— P.A6.

91. Toogood J.H. et al. Use of spacers to facilitate inhaled corticosteroid treatment of asthma / / Am.Rev.Respir.Dis.— 1984.—Vol.129.— P.723—729.

92. Toogood J.H., Baskerville J., Johansson S.A. Factors accounting for steroid resistance in chronic asthma / / Chest.— 1985.— Vol.88, № 1.— P.529.

93. Toogood J.H., Baskerville J.C., Jennings B., Lefcoe N.M., Johansson S.A. Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide / / J.Allergy Clin.Immunol.— 1992.— Vol.70.— P.288—298.

94. Toogood J.H., Crilly R.G., Jones G., Nadean J., Wells G.A. Effect of high-dose inhaled budesonide on calcium and phosphate metabolism and the risk of osteoporosis / / Am.Rev.Respir.Dis.—1988.— Vol.138.— P.57—61.

95. Toogood J.H., Lefcoe N.M., Haines D.S.M. et al. A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma / / J.Allergy Clin.Immunol.— 1977.— Vol.59,— P.298—308.

96. Toogood J.H., Lefcoe N.M., Haines D.S.M. et al. Minimum dose requirements of steroid-dependent asthmatic patients for aerosol beclomethasone and oral prednisolone / / Ibid.— 1978.— Vol.61.—P.355—364.

97. Toogood J.H., Jennings B., Baskerville J., Lefcoe N., Newhonse M. Assessment of a device for reducing oropharyngeal complications during beclomethasone treatment of asthma / / Am.Rev. Respir. Dis.— 1982.— Vol.123.— P.113— 114.

98. Van Essen-Zandvliet E. Early intervention with inhaled corticosteroids in asthma / / Asthma Management. Topics for the 90s. A Symposium Report. Clinical Vision Ltd. 2-nd Ed.— Helsinki, 1994. p.27—35.

99. Vaz R., Senior B., Morris M., Binkiewich A. Adrenal effects of beclomethasone inhalation therapy in asthmatic children / / J.Pediatr.— 1982.— Vol.100.— P.660—662.

100. Venge P., Dahl R., Karlstroom R., Pedersen B., Peterson G.G. B. Eosinophil and neutrophil activity in asthma in a one-year double blind trial with theophylline and two doses of inhaled budesonide. Abstract / / J.Allergy Clin.Immunol.— 1992.— Vol.89.— P. 190.

101. Wales J.K.H., Barnes N.D., Swift P.G.F. Growth retardation in children on steroids for asthma / / Lancet.— 1991.— P.338.

102. Weiss K.B., Gergen P.J., Hodson T.A. An economic evaluation of asthma in the United States / / N.Engl.J.Med.— 1992.— Vol.326.—P.862—866.

103. Williams A.J., Baghat M.S., Stableforth D.E., Cayton R.M., Shenio P.M., Skinner C. Dysphonia caused by inhaled steroids: recognition of characteristic laryngeal abnormality / / Thorax.—1983.— Vol.38.— P.813—821.

104. Wolthers O.D., Juul Riis B., Pedersen S. Bone turnover in asthmatic children treated with inhaled budesonide / / Eur. Respir.J.— 1992.— Vol.5, Suppl.15.— P.31 Is.

105. Wolthers O.D., Pedersen S. Controled study of 1 in ear growth in asthmatics children during treatment with inhaled glucocorticoids / / Pediatrics.— 1992,— Vol.89.— P.839-842.

106. Wolthers O.D., Pedersen S. Growth of asthmatic children during treatment with budesonide: a double-blind trial / / Br.Med.J.—1991.— Vol.303.— P.163— 165.

107. Wolthers O.D., Pedersen S. Linear growth in asthmatic schoolchildren treated with inhaled budesonide / / Eur.Respir.J.— 1992.— Vol.5, Suppl.15.— P.311s.

108. Wong J., Black P. Acute adrenal in sufficiency associated with high dose inhaled steroids. Correspondence / / Br.Med.J.— 1992,— Vol.304.— P. 1415.

109. Woolcoch A.J., Van K., Salome C.M. Effect of therapy on bronchial hyperresponsiveness in the long-term management of asthma / / Clin.Allergy.— 1988.— Vol. 18,— P.65.

110. Wya H.R., Washek J., Weinberger M., Sherman B. Effects of inhaled beclomethasone dipropionate and alternate-day prednisolone on pituitary-adrenal function in children with chronic asthma / / N.Engl.J.Med.— 1978.— Vol.299.— P.1387— 1392.